Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Apr 2007 10:18

ViaLogy PLC05 April 2007 Date: 5 April 2007On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy plc Technology Update • ViaLogy offers aerospace industry a highly scaleable platform for integrating emerging wireless MEMS and RFID Devices • Will potentially accelerate adoption of lightweight composites for aerospace and semiconductor applications LONDON, April 5, 2007 -- ViaLogy plc (AIM: VIY): ViaLogy presented a network-centric interoperable sensor- signal- processing platform deployingembedded MEMS and RFID sensors at the CANEUS/NASA "Fly-By-Wireless" Workshopheld in conjunction with the 5th Annual RFID World Congress in Grapevine, TX. Lightweight composites are becoming increasingly important in aircraft,aerospace structures, transportation systems and underground oil and gaspipelines. To date, most of the work has focused on deploying and machiningcomposites for control surfaces, skin, structures and cryogenic tanks andvessels. While high stiffness, strength, superior fatigue tolerance to thermalvariations and stealthy radar cross section make composites very attractive,their adoption has been rather limited due to high cost, manufacturability,complex failure mechanisms and maintainability. Typically, design-to-reliabilitychallenges can be overcome with additional structure health monitoring circuitryand sensors. However, this is very difficult to achieve for composites withcurrent technology, without surface mounting hundreds of hardwired stress andstrain gauges and other sensors to detect incipient micro-fracture which canrapidly degenerate to total structure failure. Thus aerospace and reusablelaunch vehicle engineering has been limited in exploiting the promise ofcomposites due to weight and power overhead from additional sensors. ViaLogy's Pulsed Microwave Data Link (PMDLTM) platform combines synergisticadvances in MEMS sensors, power optimized active radio-frequency (RF) scanningfor embedded MEMS/RFID tag interrogation, internet protocol-enabled MEMSinteroperability for wireless interconnect switches, smart summarization andweak signal processing to extract diagnostic signatures. ViaLogy has a patentpending on this solution. PMDLTM addresses two challenges unique to embedded wireless MEMS/RFIDimplementations with inherent requirements for high scalability; namelycontinuous monitoring for degradation, recalibration and mortality of thedevices themselves and resulting uncertainty in signature quality, and abilityof proprietary weak signal processing to robustly extract failure-modes andsignatures in high clutter RF environments with complex propagation propertiesintrinsic to molecular constructs seen in composites. Dr. Sandeep Gulati, ViaLogy CTO and VP for Product Development, commented; "Weare focused on broad market applications where our network centric and sensoragnostic weak signal processing platform becomes an enabler. In addition, we seea convergence between our wireless MEMS and RFID solutions and an immediatevalue proposition in increasing RFID read accuracy for embedded tags in theaerospace industry." Dr. John Mai, Product Manager for RFID Platforms, recently joined ViaLogy tohead this effort. Previously, Dr. Mai was the Special Assistant to the GeneralDirector of the RFID Technology Center (RTC) within the Industrial TechnologyResearch Institute, Hsinchu, Taiwan. There, he was involved with all of theCenter's advanced projects ranging from all-printed RFID developments to next-generation, compact UHF RFID readers. He also initiated a polymer-MEMS device R&D program between the RTC and Stanford University. According to Dr. Mai, an aerospace engineer by training; "Localizing a crack ina epoxy composite cryogenic propellant tank using embedded MEMS sensors orcorrectly reading a metallic RFID tag embedded within a multilayer compositeprinted circuit board, buried deep in a loaded pallet present the same clutterrejection challenge. There is an economic penalty which can quickly propagateand escalate for missed detection in both cases." He added, "As the supply-chainindustry moves towards item level tagging, fast and accurate read capabilityenabled by PMDLTM, will become a market differentiator". Dr. Mai is leveraging his experience in business with the Asia-Pacific region toposition this ViaLogy solution into a market that it is believed could consume48% of the world's RFID tags by 2010. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626 296 6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.